🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Up to 90% of patients with Parkinson's disease (PD) have hypokinetic dysart...
Status
Unknown
Location
Central European Institute of Technology
Start Date
2023-01-10
Trial ID
NCT06416553
Medication is an efficacious treatment strategy for adolescents with attent...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2020-06-01
Trial ID
NCT04386096
The systematic inclusion of spinal muscular atrophy (SMA) in France's neona...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-20
Trial ID
NCT07208903
Treatments Being Tested
Primary purpose: Frequency of use of broad-spectrum antifungals in the epis...
Status
Completed
Location
Hospital Clínic
Start Date
2006-08
Trial ID
NCT00386802
Treatments Being Tested
The purpose of this research study is to learn about the effectiveness of u...
Status
Completed
Location
Penrose Cancer Center
Start Date
2012-02-07
Trial ID
NCT01530997
Treatments Being Tested
Patients with advanced rectal cancer can sometimes have suspected tumour af...
Status
Not Yet Recruiting
Location
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Start Date
2025-09-15
Trial ID
NCT06896578
Treatments Being Tested
The purpose of this study is to learn about the study medicine CTB-AVP for ...
Status
Completed
Location
Pfizer Clinical Research Unit - Brussels
Start Date
2024-07-29
Trial ID
NCT06593054
Treatments Being Tested
This study will identify the optimum concentrations of AGN-199201 and AGN-1...
Status
Completed
Location
Sall Research Medical Center
Start Date
2016-04-29
Trial ID
NCT02595528
Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Start Date
2021-06-25
Trial ID
NCT04604067
Treatments Being Tested